The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Why have clinical trials in sepsis failed?
Abstract
The systemic inflammatory response is biologically complex, redundant, and activated by both infectious and noninfectious triggers. Its manipulation can cause both benefit and harm. More than 100 randomized clinical trials have tested the hypothesis that modulating the septic response to infection can improve survival. With one short-lived exception, none of these has resulted in new treatments. The current challenge for sepsis research lies in a failure of concept and reluctance to abandon a demonstrably ineffectual research model. Future success will necessitate large studies of clinical and biochemical epidemiology to understand the course of illness, better integration of basic and clinical science, and the creation of stratification systems to target treatment towards those who are most likely to benefit.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The underlying molecular mechanisms behind pathological capillary leakage remain incompletely understood, hindering the development of targeted therapies aimed at vascular stabilization (3).”
From Targeting β1-integrin inhibits vascular leakage in endotoxemia (2018) · cites this paper as [3]
In the citing paper
“Increased capillary leakage leading to hypovolemic shock and multiorgan failure is a key event in the pathobiology of several difficult-to-treat conditions, such as sepsis (2, 3, 6).”
From Targeting β1-integrin inhibits vascular leakage in endotoxemia (2018) · cites this paper as [3]
In the citing paper
“Over the last 40 years, more than 100 clinical trials of would‐be sepsis drugs aimed at modulating host immune responses to infection have failed.”
From On race, human variation, and who gets and dies of sepsis (2022) · cites this paper as Marshall, 2014
Citations
Cites
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,335
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J., Laterre, P., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,124
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E. H., Angus, D. C., Cook, D., Cohen, J., Opal, S. M., Vincent, J., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,976
Self-citationIntensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Genomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Functional Disability 5 Years after Acute Respiratory Distress Syndrome
Herridge, M. S., Tansey, C. M., Matte, A. L., TOMLINSON, G. A., Diaz-Granados, N., Cooper, A., Guest, C. B., Mazer, C. D., Mehta, S., Stewart, T. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011802 · Cited by 2,892
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448
Research works printed but not linked: 1
- Centers for Disease Control and Prevention, 1999, Achievements in public health, 1900–1999, MMWR, 48, 621
Cited by
Sorted by citations
Items 101–200 of 810
Lawler, P. R., Berg, D. D., Park, J., Katz, J. N., Baird-Zars, V. M., Barsness, G. W., Bohula, E. A., Carnicelli, A., Chaudhry, S., Jentzer, J. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004948 · Cited by 90
Sepsis subphenotypes, theragnostics and personalized sepsis care
Antcliffe, D. B., Burrell, A. J. C., Boyle, A. J., Gordon, A. C., McAuley, D. F., & Silversides, J. A. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-07873-6 · Cited by 99
Human resistin protects against endotoxic shock by blocking LPS–TLR4 interaction
Jang, J. C., Li, J., Gambini, L., Batugedara, H., Sati, S., Lazar, M. A., Fan, L., Pellecchia, M., & Nair, M. G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716015114 · Cited by 86
Buzzelli, J. N., Ouaret, D., Brown, G., Allen, P. D., & Muschel, R. J. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.01.016 · Cited by 87
Sepsis, oxidative stress, and hypoxia: Are there clues to better treatment?
Bar‐Or, D., Carrick, M. M., Mains, C. W., Rael, L. T., Slone, D. S., & Brody, E. N. (2015) · Redox Report · doi:10.1179/1351000215y.0000000005 · Cited by 87
Caslin, H. L., Abebayehu, D., Qayum, A. A., Haque, T. T., Taruselli, M. T., Paez, P. A., Pondicherry, N., Barnstein, B. O., Hoeferlin, L. A., Chalfant, C. E., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801005 · Cited by 87
Kuhn, S.-O., Meissner, K., Mayes, L. M., & Bartels, K. (2018) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000549 · Cited by 82
Exploring the role of antioxidants in sepsis-associated oxidative stress: a comprehensive review
Sahoo, D. K., Wong, D. M., Patani, A., Paital, B., Yadav, V. K., Patel, A., & Jergens, A. E. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1348713 · Cited by 89
Cargo-less nanoparticles program innate immune cell responses to toll-like receptor activation
Casey, L. M., Kakade, S., Decker, J. T., Rose, J. A., Deans, K. W., Shea, L. D., & Pearson, R. M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119333 · Cited by 83
Wang, Y., Tang, B., Li, H., Zheng, J., Zhang, C., Yang, Z., Tan, X., Luo, P., Ma, L., Wang, Y., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104480 · Cited by 81
Delabranche, X., Quenot, J., Lavigne, T., Mercier, E., François, B., Séverac, F., Grunebaum, L., Mehdi, M. K. I. M., Zobairi, F., Toti, F., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001836 · Cited by 79
Itaconate: A Metabolite Regulates Inflammation Response and Oxidative Stress
Li, R., Zhang, P., Wang, Y., & Tao, K. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5404780 · Cited by 81
Precision management of acute kidney injury in the intensive care unit: current state of the art
Stanski, N. L., Rodrigues, C. E., Strader, M., Murray, P. T., Endre, Z. H., & Bagshaw, S. M. (2023) · Intensive Care Medicine · doi:10.1007/s00134-023-07171-z · Cited by 79
Role of Platelets in Inflammation
Arman, M., Payne, H., Ponomaryov, T., & Brill, A. G. (2015) · InTech eBooks · doi:10.5772/60536 · Cited by 81
Hager, D. N., Hooper, M. H., Bernard, G. R., Busse, L. W., Ely, E. W., Fowler, A. A., Gaieski, D. F., Hall, A. J., Hinson, J. S., Jackson, J. C., et al. (2019) · Trials · doi:10.1186/s13063-019-3254-2 · Cited by 75
Tung, J., Chiaretti, S., Dean, M. M., Sultana, A. J., Reade, M. C., & Fung, Y. L. (2022) · Blood Reviews · doi:10.1016/j.blre.2021.100926 · Cited by 79
Aman, J., Weijers, E. M., Amerongen, G. P. V. N., Malik, A. B., & van Hinsbergh, V. W. M. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00393.2015 · Cited by 71
Mitochondrial Dysfunction and Immune Cell Metabolism in Sepsis
Park, D. W., & Zmijewski, J. W. (2017) · Infection and Chemotherapy · doi:10.3947/ic.2017.49.1.10 · Cited by 71
Therapeutic interventions in sepsis: current and anticipated pharmacological agents
Shukla, P., Rao, G. M., Pandey, G., Sharma, S., Mittapelly, N., Shegokar, R., & Mishra, P. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12829 · Cited by 71
Wang, X., Xia, Z., Wang, H., Wang, D., Sun, T., Hossain, E., Pang, X., & Liu, Y. (2023) · Theranostics · doi:10.7150/thno.81520 · Cited by 72
Recognizing and managing sepsis: what needs to be done?
Yealy, D. M., Huang, D. T., Delaney, A. P., Knight, M., Randolph, A. G., Daniels, R., & Nutbeam, T. (2015) · BMC Medicine · doi:10.1186/s12916-015-0335-2 · Cited by 73
Shankar‐Hari, M., Culshaw, N., Post, B., Tamayo, E., Andaluz‐Ojeda, D., Bermejo-Martín, J. F., Dietz, S., Werdan, K., Beale, R. J., Spencer, J., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3845-7 · Cited by 71
Assessing clinical heterogeneity in sepsis through treatment patterns and machine learning
Fohner, A. E., Greene, J., Lawson, B. L., Chen, J. H., Kipnis, P., Escobar, G. J., & Liu, V. X. (2019) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocz106 · Cited by 74
Chang, J. C. (2018) · Thrombosis Journal · doi:10.1186/s12959-018-0174-4 · Cited by 69
Mi, Y., Burnham, K. L., Charles, P. D., Heilig, R., Vendrell, I., Whalley, J. P., Torrance, H. D. T., Antcliffe, D. B., May, S. M., Neville, M. J., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adh0185 · Cited by 77
A consensus blood transcriptomic framework for sepsis
Scicluna, B. P., Cano-Gamez, K., Burnham, K. L., Davenport, E. E., Moore, A. R., Khan, S., Hinds, C., Cremer, O. L., Khatri, P., Sweeney, T. E., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03964-5 · Cited by 80
Lakshmikanth, C. L., Jacob, S. P., Chaithra, V. H., Castro-Faria-Neto, H. C., & Marathe, G. K. (2016) · Inflammation Research · doi:10.1007/s00011-016-0937-y · Cited by 75
Belsky, J., Wira, C., Jacob, V., Sather, J., & Lee, P. J. (2018) · Nutrition Research Reviews · doi:10.1017/s0954422418000124 · Cited by 70
Moen, S. H., Ehrnström, B., Kojen, J. F., Yurchenko, M., Beckwith, K. S., Afset, J. E., Damås, J. K., Hu, Z., Yin, H. H., Espevik, T., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01209 · Cited by 69
Zador, Z. E., Landry, A., Cusimano, M. D., & Geifman, N. (2019) · Critical Care · doi:10.1186/s13054-019-2486-6 · Cited by 68
Darden, D. B., Brakenridge, S. C., Efron, P. A., Ghita, G. L., Fenner, B. P., Kelly, L. S., Mohr, A. M., Moldawer, L. L., & Moore, F. A. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000005067 · Cited by 68
Schäfer, S. T., Franken, L., Adamzik, M., Schumak, B., Scherag, A., Engler, A., Schönborn, N., Walden, J., Koch, S., Baba, H. A., et al. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001008 · Cited by 70
Salazar, F., Awuah, D., Negm, O. H., Shakib, F., & Ghaemmaghami, A. M. (2017) · Scientific Reports · doi:10.1038/srep43337 · Cited by 69
Hoffman, M., Kyriazis, I. D., Lucchese, A. M., de Lucia, C., Piedepalumbo, M., Bauer, M. W., Schulze, P. C., Bonios, M. J., Koch, W. J., & Drosatos, K. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012260 · Cited by 68
Development of a Zebrafish Sepsis Model for High-Throughput Drug Discovery
Philip, A. M., Wang, Y., Mauro, A., El‐Rass, S., Marshall, J. C., Lee, W. L., Slutsky, A. S., dos Santos, C. C., & Wen, X. (2017) · Molecular Medicine · doi:10.2119/molmed.2016.00188 · Cited by 67
Self-citationRole of regulation of PD-1 and PD-L1 expression in sepsis
Zhang, T., Yu-Jing, L., & Ma, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1029438 · Cited by 75
Insulin Reduces Inflammation by Regulating the Activation of the NLRP3 Inflammasome
Chang, Y., Hung, L.-C., Chen, Y., Wang, W., Lin, C., Tzeng, H.-H., Suen, J., & Chen, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587229 · Cited by 67
The Central Role of the Inflammatory Response in Understanding the Heterogeneity of Sepsis-3
Ding, R., Meng, Y., & Ma, X. (2018) · BioMed Research International · doi:10.1155/2018/5086516 · Cited by 68
Immune therapy in sepsis: Are we ready to try again?
Davies, R., O'Dea, K. P., & Gordon, A. C. (2018) · Journal of the Intensive Care Society · doi:10.1177/1751143718765407 · Cited by 68
The leukocyte non-coding RNA landscape in critically ill patients with sepsis
Scicluna, B. P., Uhel, F., van Vught, L. A., Wiewel, M. A., Hoogendijk, A. J., Baessmann, I., Franitza, M., Nürnberg, P., Horn, J., Cremer, O. L., et al. (2020) · eLife · doi:10.7554/elife.58597 · Cited by 61
Carbon monoxide in the treatment of sepsis
Nakahira, K., & Choi, A. M. K. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00311.2015 · Cited by 67
Oami, T., Watanabe, E., Hatano, M., Teratake, Y., Fujimura, L., Sakamoto, A., Ito, C., Toshimori, K., Swanson, P. E., & Oda, S. (2017) · Shock · doi:10.1097/shk.0000000000001040 · Cited by 63
Virga, F., Cappellesso, F., Stijlemans, B., Henze, A., Trotta, R., Audenaerde, J. R. M. V., Mirchandani, A. S., Sánchez-García, M. A., Vandewalle, J., Orso, F., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf0466 · Cited by 67
Outgrowing the Immaturity Myth: The Cost of Defending From Neonatal Infectious Disease
Harbeson, D. J., Ben-Othman, R., Amenyogbe, N., & Kollmann, T. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01077 · Cited by 66
Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting
Kumar, V. (2018) · Inflammation · doi:10.1007/s10753-018-0939-8 · Cited by 66
Decoding inflammation, its causes, genomic responses, and emerging countermeasures
Hawiger, J., & Zienkiewicz, J. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12812 · Cited by 62
Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis
Nierhaus, A., Berlot, G., Kindgen‐Milles, D., Müller, E. E., & Girardis, M. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00740-1 · Cited by 62
Roggeveen, L. F., Guo, T., Fleuren, L. M., Driessen, R. H., Thoral, P., van Hest, R. M., Mathôt, R. A. A., Swart, E. L., de Grooth, H., van den Bogaard, B., et al. (2022) · Critical Care · doi:10.1186/s13054-022-04098-7 · Cited by 59
Sinha, P., Spicer, A. B., Delucchi, K., McAuley, D. F., Calfee, C. S., & Churpek, M. M. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103697 · Cited by 58
Xue, M., Xie, J., Liu, L., Huang, Y., Guo, F., Xu, J., Yang, Y., & Qiu, H. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1811-9 · Cited by 58
Targeting Toll-Like Receptors in Sepsis: From Bench to Clinical Trials
Chen, F., Zou, L., Williams, B., & Chao, W. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0005 · Cited by 62
Matrine suppresses NLRP3 inflammasome activation via regulating PTPN2/JNK/SREBP2 pathway in sepsis
Wang, X., Wu, F.-P., Huang, Y., Li, H., Cao, X., You, Y., Meng, Z., Sun, K., & Shen, X. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154574 · Cited by 61
Gould, T. J., Lysov, Z., Swystun, L. L., Dwivedi, D. J., Zarychanski, R., Fox‐Robichaud, A., & Liaw, P. C. (2016) · Shock · doi:10.1097/shk.0000000000000680 · Cited by 59
How Clinical Flow Cytometry Rebooted Sepsis Immunology
Monneret, G., Gossez, M., Aghaeepour, N., Gaudilliere, B. L., & Venet, F. (2019) · Cytometry Part A · doi:10.1002/cyto.a.23749 · Cited by 59
MicroRNA‐155: Regulation of Immune Cells in Sepsis
Chen, M., Wang, F., Xia, H., & Yao, S. (2021) · Mediators of Inflammation · doi:10.1155/2021/8874854 · Cited by 59
Sepsis-related mortality in 497 cases with blood culture-positive sepsis in an emergency department
Rannikko, J., Syrjänen, J., Seiskari, T., Aittoniemi, J., & Huttunen, R. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.03.005 · Cited by 57
Accelerated Aging and Clearance of Host Anti-inflammatory Enzymes by Discrete Pathogens Fuels Sepsis
Yang, W. H., Heithoff, D. M., Aziz, P. V., Haslund-Gourley, B. S., Westman, J. S., Narisawa, S., Pinkerton, A. B., Millán, J. L., Nizet, V., Mahan, M. J., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.09.011 · Cited by 56
Ibáñez-Cabellos, J. S., Aguado, C., Pérez‐Cremades, D., García‐Giménez, J. L., Bueno‐Betí, C., García-López, E., Mateo, C. R., Novella, S., Hermenegildo, C., & Pallardó, F. V. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.07.010 · Cited by 55
Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study
Stortz, J. A., Cox, M. C., Hawkins, R. B., Ghita, G. L., Brumback, B., Mohr, A. M., Moldawer, L. L., Efron, P. A., Brakenridge, S. C., & Moore, F. A. (2020) · Critical Care · doi:10.1186/s13054-020-02917-3 · Cited by 55
Preclinical target validation using patient-derived cells
Edwards, A. M., Arrowsmith, C. H., Bountra, C., Bunnage, M. E., Feldmann, M., Knight, J. C., Patel, D. D., Prinos, P., Taylor, M. D., Sundström, M., et al. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4565 · Cited by 54
Self-citationGondorf, F., Berbudi, A., Buerfent, B. C., Ajendra, J., Bloemker, D., Specht, S., Schmidt, D., Neumann, A., Layland, L. E., Hoerauf, A. M., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004616 · Cited by 56
Generalizable Biomarkers in Critical Care: Toward Precision Medicine
Sweeney, T. E., & Khatri, P. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002402 · Cited by 55
Sharma, A., Yang, W.-L., Ochani, M., & Wang, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-08711-6 · Cited by 55
Use of Intravenous Immunoglobulins in Sepsis Therapy—A Clinical View
Jarczak, D., Kluge, S., & Nierhaus, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155543 · Cited by 59
Sirtuin-2 Regulates Sepsis Inflammation in ob/ob Mice
Wang, X., Buechler, N. L., Martin, A., Wells, J. D., Yoza, B. K., McCall, C. E., & Vachharajani, V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160431 · Cited by 53
Precision medicine in pediatric sepsis
Atreya, M. R., & Wong, H. R. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000753 · Cited by 52
Compartmentalisation of immune responses in critical illness: does it matter?
Morris, A. C., Rynne, J., & Shankar‐Hari, M. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06871-2 · Cited by 52
Wang, L., Ko, E. R., Gilchrist, J. J., Pittman, K. J., Rautanen, A., Pirinen, M., Thompson, J. W., Dubois, L. G., Langley, R. J., Jaslow, S. L., et al. (2017) · Science Advances · doi:10.1126/sciadv.1602096 · Cited by 52
Arguing for Adaptive Clinical Trials in Sepsis
Talisa, V. B., Yende, S., Seymour, C. W., & Angus, D. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01502 · Cited by 52
Singer, M., Angus, D., Annane, D., Bauer, M. W., Kalil, A. C., Klompas, M., Machado, F. R., Martin, G. S., Randolph, A. G., Shankar‐Hari, M., et al. (2026) · The Lancet · doi:10.1016/s0140-6736(25)02422-5 · Cited by 62
Inhibiting DNA Methylation Improves Survival in Severe Sepsis by Regulating NF-κB Pathway
Cao, L., Zhu, T., Lang, X., Jia, S., Yang, Y., Zhu, C., Wang, Y., Feng, S., Wang, C., Zhang, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01360 · Cited by 54
Dieleman, J. M., Peelen, L. M., Coulson, T. G., Tran, T., Reid, C. M., Smith, J. A., Myles, P. S., & Pilcher, D. V. (2017) · British Journal of Anaesthesia · doi:10.1093/bja/aex239 · Cited by 52
Enterobactin inhibits microbiota-dependent activation of AhR to promote bacterial sepsis in mice
Keskey, R. C., Xiao, J. F., Hyoju, S. K., Lam, A., Kim, D., Sidebottom, A. M., Zaborin, A., Dijkstra, A., Meltzer, R. S., Thakur, A., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-024-01882-9 · Cited by 54
Is Mortality a Useful Primary End Point for Critical Care Trials?
Veldhoen, R. A., Howes, D. W., & Maslove, D. M. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.11.019 · Cited by 49
Martínez-Espinosa, I., Serrato, J. A., & Ortíz-Quintero, B. (2021) · Biomolecules · doi:10.3390/biom12010004 · Cited by 50
Gatica‐Andrades, M., Vagenas, D., Kling, J. C., Nguyen, T. T. K., Benham, H., Thomas, R., Körner, H., Venkatesh, B., Cohen, J., & Blumenthal, A. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017006163 · Cited by 49
Frencken, J. F., van Vught, L. A., Peelen, L. M., Ong, D. S. Y., Klouwenberg, P. M. C. K., Horn, J., Bonten, M. J. M., van der Poll, T., & Cremer, O. L. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002292 · Cited by 48
Goh, C., & Knight, J. C. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30045-0 · Cited by 51
Towards precision medicine for sepsis patients
Pickkers, P., & Kox, M. (2017) · Critical Care · doi:10.1186/s13054-016-1583-z · Cited by 48
Nandi, M., Jackson, S. K., Macrae, D. J., Shankar‐Hari, M., Tremoleda, J. L., & Lilley, E. J. (2020) · Clinical Science · doi:10.1042/cs20200679 · Cited by 50
Kalimuddin, S., Chia, P. Y., Low, J. G. H., & Ooi, E. E. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00244-24 · Cited by 50
Walley, K. R. (2016) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000351 · Cited by 47
miR-146a targeted to splenic macrophages prevents sepsis-induced multiple organ injury
Funahashi, Y., Kato, N., Masuda, T., Nishio, F., Kitai, H., Ishimoto, T., Kosugi, T., Tsuboi, N., Matsuda, N., Maruyama, S., et al. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0190-4 · Cited by 47
Leveraging transcriptomics for precision diagnosis: Lessons learned from cancer and sepsis
Tsakiroglou, M., Evans, A. G., & Pirmohamed, M. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1100352 · Cited by 49
Cox, M. C., Brakenridge, S. C., Stortz, J. A., Hawkins, R. B., Darden, D. B., Ghita, G. L., Mohr, A. M., Moldawer, L. L., Efron, P. A., & Moore, F. A. (2020) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2020.07.016 · Cited by 47
Immunosuppression in Sepsis: Biomarkers and Specialized Pro-Resolving Mediators
Padovani, C. M., & Yin, K. (2024) · Biomedicines · doi:10.3390/biomedicines12010175 · Cited by 48
Hirano, Y., Ode, Y., Ochani, M., Wang, P., & Aziz, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0218-050r · Cited by 45
Brook, B., Harbeson, D. J., Ben-Othman, R., Viemann, D., & Kollmann, T. R. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0651-z · Cited by 46
Estimating attributable fraction of mortality from sepsis to inform clinical trials
Shankar‐Hari, M., Harrison, D. A., Rowan, K., & Rubenfeld, G. D. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.01.018 · Cited by 46
Switch of NAD Salvage to de novo Biosynthesis Sustains SIRT1-RelB-Dependent Inflammatory Tolerance
Zhang, J., Tao, J., Ling, Y., Li, F., Zhu, X., Xu, L., Wang, M., Zhang, S., McCall, C. E., & Liu, T. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02358 · Cited by 48
Jung, S., Lee, M., Baek, M. S., & Kim, W. (2022) · Critical Care · doi:10.1186/s13054-021-03872-3 · Cited by 47
Braga, D., Barcella, M., Herpain, A., Aletti, F. M., Kistler, E. B., Pinto, B. B., Bendjelid, K., & Barlassina, C. (2019) · Critical Care · doi:10.1186/s13054-019-2670-8 · Cited by 43
Chang, J. C. (2020) · Thrombosis Journal · doi:10.1186/s12959-020-00231-0 · Cited by 43
Pieroni, M., Olier, I., Ortega‐Martorell, S., Johnston, B. W., & Welters, I. D. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.915224 · Cited by 44
Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review
MacKenzie, M., & Hall, R. (2016) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-016-0748-1 · Cited by 44
Koutsogiannaki, S., Schaefers, M. M., Okuno, T., Ohba, M., Yokomizo, T., Priebe, G. P., DiNardo, J. A., Soriano, S., & Yuki, K. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw261 · Cited by 42
Long Non-Coding RNAs as Biomarkers and Therapeutic Targets in Sepsis
Wang, C., Liang, G., Shen, J., Kong, H., Wu, D., Huang, J., & Li, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.722004 · Cited by 42
Atreya, M. R., Cvijanovich, N. Z., Fitzgerald, J. C., Weiss, S. L., Bigham, M. T., Jain, P., Schwarz, A. J., Lutfi, R., Nowak, J. E., Allen, G. L., et al. (2022) · Critical Care · doi:10.1186/s13054-022-04070-5 · Cited by 41
Li, R., Meng, M., Chen, Y., Pan, T., Li, Y., Deng, Y., Zhang, R., Tian, R., Xu, W., Zheng, X., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05932-8 · Cited by 41
Overcoming Translational Barriers in Acute Kidney Injury
Zuk, A., Palevsky, P. M., Fried, L. F., Harrell, F. E., Khan, S. S., McKay, D. B., Devey, L. R., Chawla, L. S., deCaestecker, M. P., Kaufman, J. S., et al. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06820617 · Cited by 40
Metadata
- Authors
- Marshall, J. C.
- Affiliations
- St. Michael's Hospital (CA)
- Corresponding author
- Marshall, John C.
- ORCID
- Marshall, John C.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 20
- Issue
- 4
- Pages
- 195-203
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W1991209345
- Cited by
- 805
- References
- 56
- Citations by year
- 2026: 77 · 2025: 75 · 2024: 69 · 2023: 75 · 2022: 96 · 2021: 66 · 2020: 72 · 2019: 69 · 2018: 59 · 2017: 62 · 2016: 45 · 2015: 28 · 2014: 12
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Keywords
- sepsis, clinical trial failure, systemic inflammatory response, sepsis treatment, translational research, patient stratification, sepsis epidemiology, inflammatory markers
- MeSH terms
- Animals, Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Immunity, Innate, Immunologic Factors, Treatment Outcome, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review